Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash and Short Term Investments (Quarterly): 205.12M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 205.12M |
| June 30, 2023 | 208.20M |
| March 31, 2023 | 236.63M |
| December 31, 2022 | 197.98M |
| September 30, 2022 | 212.43M |
| June 30, 2022 | 224.80M |
| Date | Value |
|---|---|
| March 31, 2022 | 232.04M |
| December 31, 2021 | 244.66M |
| September 30, 2021 | 90.40M |
| June 30, 2021 | 97.59M |
| December 31, 2020 | 8.457M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.457M
Minimum
Dec 2020
244.66M
Maximum
Dec 2021
178.03M
Average
208.20M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 1.263B |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |
| iBio Inc | 5.302M |
| Theriva Biologics Inc | 18.26M |